M.D. Sass has been a leading name in investment management since 1972. Today, M.D. Sass and its affiliates manage a spectrum of equity, fixed income, hedge fund and private equity strategies for some of the world's largest financial institutions, state and local governments, Fortune 500 and other corporations, endowment funds, foundations, Taft Hartley funds and high net worth individuals.
We offer the following mutual funds:
A portfolio of rigorously analyzed short duration U.S. Agency securities focused on those with the highest yield, stable cash flows and appreciation potential seeking to:
- Provide high interest income
- Preserve capital in adverse markets
- Produce capital growth, when and as opportunities are available
- Offer a value-added, short-term fixed income solution
The combination of the Equity Income Plus Fund's diversified portfolio of dividend paying common stocks, PLUS potential cash flow from the sale of covered call options and additional downside protection potential from the purchase of index put options seeks to provide the fund with:
- Positive absolute returns over time
- High cash flow
- Less interest sensitivity than bonds with less downside risk than the equity market
- Potentially lower volatility than the S&P 500
Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Fund performance current to the most recent month-end may be lower or higher than the performance quoted and can be obtained by calling 1-855-637-3863. Fund performance current to the most recent month-end may be lower or higher than the performance quoted and can be obtained by calling 1-855-637-3863. Click here for the most recent quarterly performance for the Short Term US Government Agency Income Fund and here for the Equity Income Plus Fund.
As of February 29, 2016, the Fund converted its Class C shares into Retail Class shares of the Fund and the Retail Class shares will be renamed Investor Class shares. As of January 28, 2016, the Fund's maximum sales charge imposed on purchases of Retail Class shares has been eliminated.